Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs diclofenac for chronic low back pain
2004-000487-27Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in chronic low back pain (CLBP) (2 arms), sponsored by Merck & Co. Primary endpoint: Primary efficacy: time-weighted average change in low back pain intensity over 4 weeks. Started Jul 2004; status: completed.
02
Drugs
etoricoxib
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2004-000487-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000487-27.